Leading CRO enhances nano-formulation service offerings with state-of-the-art High-Shear Microfluidics Reaction Technology (MRT) for revolutionary bottom-up nanoparticle creation
Newton, MA (PRWEB) July 8, 2010 -- Microfluidics (OTCBB: MFLU), the exclusive global provider of Microfluidizer® high shear fluid processors, and Particle Sciences Inc. (PSI), an integrated provider of drug development services, have expanded their partnership to include bottom-up nanoparticle creation and continuous manufacturing via High-Shear Microfluidics Reaction Technology™ (MRT).
“The pharmaceutical, chemical and energy industries continue to tell us that implementing a viable solution for continuous manufacturing is a strategic priority over the next few years,” said Bill Kober, Microfluidics Vice President of Sales for the Americas. “With High-Shear MRT, we believe we have developed a unique technology for crystallization and chemical reactions that has the potential to revolutionize large-scale production of drugs and chemicals worldwide. Due to our expanded collaboration with an innovative thought leader such as Particle Sciences, more pharmaceutical companies will be able to take advantage of the process consulting and product operation expertise required to optimize the commercial reward.”
Scientists from PSI continue to work alongside research engineers in the Microfluidics Technology Center on how to evaluate and establish process conditions for a wide variety of applications including inhalable drug, parenteral oncology treatments and photovoltaics.
“Leading pharmaceutical companies from around the world trust PSI to help them develop formulations that improve bioavailability, stability, target delivery and production scale efficiencies,” said Mark Mitchnick, CEO at Particle Sciences. “By adding High-Shear MRT to our portfolio of capabilities, we are better able to assist customers with aggressive nanomaterial goals and continuous manufacturing platform requirements. We are excited to offer these new possibilities as an integral part of our complete suite of solutions.”
To learn more about High-shear MRT, visit www.microfluidicscorp.com.
ABOUT PARTICLE SCIENCES INC.
Particle Sciences is an integrated provider of drug development services. Particle Sciences
focuses on particulate technologies and their application in drug delivery covering all routes of administration from topical to parenteral to combination products. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email email@example.com or contact us at (610) 861-4701 for information.
Microfluidics International Corporation (OTC Bulletin Board: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.
By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit www.microfluidicscorp.com.
# # #
Read the full story at http://www.prweb.com/releases/2010/07/prweb4233654.htm.
Copyright©2010 Vocus, Inc.
All rights reserved